These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 22183934)
1. Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Jarius S; Paul F; Franciotta D; de Seze J; Münch C; Salvetti M; Ruprecht K; Liebetrau M; Wandinger KP; Akman-Demir G; Melms A; Kristoferitsch W; Wildemann B Mult Scler; 2012 Aug; 18(8):1135-43. PubMed ID: 22183934 [TBL] [Abstract][Full Text] [Related]
2. Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Leite MI; Coutinho E; Lana-Peixoto M; Apostolos S; Waters P; Sato D; Melamud L; Marta M; Graham A; Spillane J; Villa AM; Callegaro D; Santos E; da Silva AM; Jarius S; Howard R; Nakashima I; Giovannoni G; Buckley C; Hilton-Jones D; Vincent A; Palace J Neurology; 2012 May; 78(20):1601-7. PubMed ID: 22551731 [TBL] [Abstract][Full Text] [Related]
3. Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature. Ikeguchi R; Shimizu Y; Suzuki S; Shimizu S; Kabasawa C; Hashimoto S; Masuda M; Nagane Y; Utsugisawa K; Suzuki Y; Takahashi T; Utsumi H; Fujihara K; Suzuki N; Uchiyama S Clin Neurol Neurosurg; 2014 Oct; 125():217-21. PubMed ID: 25178916 [TBL] [Abstract][Full Text] [Related]
4. Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis. Ogaki K; Hirayama T; Chijiiwa K; Fukae J; Furuya T; Noda K; Fujishima K; Hattori N; Takahashi T; Okuma Y Neurologist; 2012 Mar; 18(2):76-9. PubMed ID: 22367834 [TBL] [Abstract][Full Text] [Related]
6. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease? Papais Alvarenga RM; Araújo ACRAE; Nascimento ACB; Araujo NEC; Meneguette NS; Neri VC; Papais Alvarenga M; Filho HA; Barros PO; Bento CA; Schmidt SL; Vasconcelos CCF; Alvarenga MP Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664 [TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders]. Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501 [TBL] [Abstract][Full Text] [Related]
8. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients. Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690 [TBL] [Abstract][Full Text] [Related]
10. [Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination]. Topuzova MP; Bisaga GN; Alekseeva TM; Isabekova PS; Сhaykovskaya AD; Panina EB; Pavlova TA; Ternovykh IK Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):97-106. PubMed ID: 32844638 [TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases. Bibic VC; Brust TB; Burton JM Mult Scler Relat Disord; 2019 Feb; 28():125-128. PubMed ID: 30593981 [TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068 [TBL] [Abstract][Full Text] [Related]
13. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum. Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917 [TBL] [Abstract][Full Text] [Related]
14. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M; J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675 [TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica in patients with myasthenia gravis: Two case-reports. Castro-Suarez S; Guevara-Silva E; Caparó-Zamalloa C; Cortez J; Meza-Vega M Mult Scler Relat Disord; 2020 Aug; 43():102173. PubMed ID: 32442888 [TBL] [Abstract][Full Text] [Related]
16. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206 [TBL] [Abstract][Full Text] [Related]
17. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. Jarius S; Ruprecht K; Wildemann B; Kuempfel T; Ringelstein M; Geis C; Kleiter I; Kleinschnitz C; Berthele A; Brettschneider J; Hellwig K; Hemmer B; Linker RA; Lauda F; Mayer CA; Tumani H; Melms A; Trebst C; Stangel M; Marziniak M; Hoffmann F; Schippling S; Faiss JH; Neuhaus O; Ettrich B; Zentner C; Guthke K; Hofstadt-van Oy U; Reuss R; Pellkofer H; Ziemann U; Kern P; Wandinger KP; Bergh FT; Boettcher T; Langel S; Liebetrau M; Rommer PS; Niehaus S; Münch C; Winkelmann A; Zettl U UK; Metz I; Veauthier C; Sieb JP; Wilke C; Hartung HP; Aktas O; Paul F J Neuroinflammation; 2012 Jan; 9():14. PubMed ID: 22260418 [TBL] [Abstract][Full Text] [Related]
18. Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy. von Glehn F; Jarius S; Penalva de Oliveira AC; Brandão CO; Farias AS; Damasceno A; Casseb J; Moraes AS; Longhini AL; Wandinger KP; Damasceno BP; Wildemann B; Santos LM PLoS One; 2012; 7(7):e39372. PubMed ID: 22808032 [TBL] [Abstract][Full Text] [Related]
19. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder. Camera V; Holm-Mercer L; Ali AAH; Messina S; Horvat T; Kuker W; Leite MI; Palace J JAMA Netw Open; 2021 Dec; 4(12):e2137833. PubMed ID: 34878547 [TBL] [Abstract][Full Text] [Related]
20. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]